CVAD regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: CHOD; CTX/DM/DOX/VCR; CVAD; Cyclophosphamide/Dexamethasone/Doxorubicin/Vincristine
Overview
CVAD regimen refers to a regimen consisting of cyclophosphamide, vincristine, adriamycin (Doxorubicin), dexamethasone used to treat Multiple myeloma.[1]
Regimen
CCyclophosphamide
VVincristine (Oncovin)
ADoxorubicin (Adriamycin, Hydroxydaunorubicin)
DDexamethasone
Indications
References
- ↑ 1.0 1.1 Morgan GJ, Davies FE, Gregory WM, Bell SE, Szubert AJ, Navarro Coy N; et al. (2012). “Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results”. Haematologica. 97 (3): 442–50. doi:10.3324/haematol.2011.043372. PMC 3291601. PMID 22058209.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH